M. Tsuda et al., THE DEFECTIVE SECRETION OF A NATURALLY-OCCURRING ALPHA-1-ANTICHYMOTRYPSIN VARIANT WITH A FRAMESHIFT MUTATION, European journal of biochemistry, 235(3), 1996, pp. 821-827
A newly found variant alpha-1-antichymotrypsin (ACT), ACT Isehara-2, h
as a deletion of two bases (AA) at codon 391 near the carboxyl terminu
s. This frameshift mutation caused a change in the amino acid sequence
and generated 10 extra amino acids (408 amino acids total) [Tsuda, M.
, Sei, Y., Matsumoto, M., Kamiguchi, H., Yamamoto, Y., Shinohara, Y.,
Igarashi, T. st Yamamura, M. (1992) Hum. Genet. 91, 467-468]. The seru
m ACT levels in three unrelated heterozygotes with this mutant ACT gen
e were 37%, 49% and 54% that of the normal individuals. To examine the
reduced serum levels, the normal ACT and the mutant ACT created by si
te-directed mutagenesis were transfected into COS-7 cells for comparis
on. The value for the retention rate (intracellular ACT/total ACT) was
apparently higher in the cells expressing mutant ACT Isehara-2 than t
hose bearing the normal gene. In the pulse-chase experiments, the secr
etion of the synthesized mutant ACT into the medium was not observed,
whereas the normal ACT was mostly secreted as a 64-kDa form. The endog
lycosidase H digestion and an electron microscopic analysis indicated
that the retained mutant ACT was present in the endoplasmic reticulum.
These results provide the biochemical basis for the decreased serum A
CT level of individuals with ACT Isehara-2, and suggest the importance
of the carboxyl-terminal region for its secretion.